An outer membrane protein of 50 kDa (OprK) was overproduced in a siderophore-deficient mutant of Pseudomonas aeruginosa capable of growth on iron-deficient minimal medium containing 2,2'-dipyridyl (0.5 mM). The expression of OprK in the mutant (strain K385) was associated with enhanced resistance to a number of antimicrobial agents, including ciprofloxacin, nalidixic acid, tetracycline, chloramphenicol, and streptonigrin. OprK was inducible in the parent strain by growth under severe iron limitation, as provided, for example, by the addition of dipyridyl or ZnSO4 to the growth medium. The gene encoding OprK (previously identified as ORFC) forms part of an operon composed of three genes (ORFABC) implicated in the secretion of the siderophore pyoverdine. Mutants defective in ORFA, ORFB, or ORFC exhibited enhanced susceptibility to tetracycline, chloramphenicol, ciprofloxacin, streptonigrin, and dipyridyl, consistent with a role for the ORFABC operon in multiple antibiotic resistance in P. aeruginosa. Sequence analysis of ORFC (oprK) revealed that its product is homologous to a class of outer membrane proteins involved in export. Similarly, the products of ORFA and ORFB exhibit homology to previously described bacterial export proteins located in the cytoplasmic membrane. These data suggest that ORFA-ORFB-oprK (ORFC)-dependent drug eftlux contributes to multiple antibiotic resistance in P. aeruginosa. We propose, therefore, the designation mexAB (multiple efflux) for ORFAB.
Pseudomonas aeruginosa is a clinically significant pathogen characterized by intrinsic resistance to a number of antimicrobial agents. Moreover, problems with the development of resistance to agents generally exhibiting potent antibacterial activity against this organism (e.g., carbepenems and fluoroquinolones) are encountered with increasing frequency (12, 14, 19, 41, 43, 47, 48, 54, 55, 65) . In addition, cross-resistance to chemically unrelated antibiotics can be associated with fluoroquinolone resistance (33, 43, 48, 54, 55, 62, 65) . In vitro studies of fluoroquinolone-resistant strains exhibiting cross-resistance have indicated that resistance is attributable to decreased drug accumulation resulting from alterations in outer membrane permeability (12, 14, 19, 24, 41, 43, 47, 65) . In some instances, this conclusion stems from the identification of novel outer membrane proteins in these mutants (24, 33, 43, 47) .
Fluoroquinolone resistance has also been reported for Escherichia coli, for which an energy-dependent efflux mechanism has been implicated (10, 11, 38) . Interestingly, cross-resistance to unrelated antibiotics is also a property of some of these mutants (32, 37, 38) , and multiple-antibiotic-resistant E. coli also shows cross-resistance to fluoroquinolones (11) .
Recently, we identified an operon (ORFABC) in P. aeruginosa apparently involved in pyoverdine secretion (57) . We report here the characterization of ORFC, which encodes an outer membrane protein whose overproduction is associated with multiple antibiotic resistance. Moreover , we demonstrate that the products of ORFABC show substantial homology to bacterial efflux proteins.
MATERIALS AND METHODS
Strains and plasmids. The bacterial strains and plasmids used in this study are described in Table 1 . Strain K385 is a K372 derivative isolated as a spontaneous mutant growing on * Corresponding author.
iron-deficient succinate minimal medium (see below) containing 0.5 mM 2,2'-dipyridyl.
Growth media. Iron-deficient succinate minimal medium has been described elsewhere (60) and was made iron sufficient by the addition of FeSO4 (100 ,uM). For culturing of E. coli cells, glucose (0.4% [wt/vol]) replaced succinate in the abovedescribed medium. In some experiments, a phosphate-sufficient N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES)-buffered minimal medium (28) was used as the iron-deficient medium and was similarly made iron sufficient by the addition of 100 ,uM FeSO4. Amino acids (1 mM) and thiamine-HCl (30 ,uM) were added to growth media as required. L broth (16) was used as the rich medium throughout. Ampicillin (100 ,ug/ml), carbenicillin (200 ,ug/ml), tetracycline (P. aeruginosa, 100 ,ug/ml; E. coli, 10 ,ug/ml), kanamycin (50 ,ug/ml), and HgCl2 (15 ,ug/ml) were included in growth media as necessary. Solid media were obtained by the addition of Bacto Agar (Difco; 1.5% [wt/vol] ).
Membrane isolation and SDS-polyacrylamide gel electrophoresis. Outer membranes were prepared by differential Triton X-100 solubilization of isolated cell envelopes (66) or by sucrose gradient density centrifugation (29) . Inner membranes were prepared on sucrose gradients (29) . Sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis was carried out as described previously (46) with 9 or 14% (wt/vol) acrylamide in the running gel.
Purification of OprK. Outer membranes prepared from 8 liters of P. aeruginosa K385 grown overnight in iron-sufficient succinate minimal medium were resuspended in 80 ml of 2% by 3.0 cm; Pharmacia-LKB) equilibrated with 1% Zwittergent 3-14-20 mM Tris-HCl (pH 8.0) (column buf-er A). The column was subsequently washed with 10 ml of column buffer A and then with 5 ml of column buffer A containing 0.1 M NaCl. Bound protein was eluted from the column with a 40-ml linear gradient of NaCl (0.1 to 0.4 M) in column buffer A and collected in 1-ml fractions. Fractions enriched for OprK (as determined by SDS-polyacrylamide gel electrophoresis) were pooled and dialyzed overnight against 1% Zwittergent 3-14-10 mM Na2HPO4-NaH2PO4 buffer (pH 7.0)-0.1 M NaCl (column buffer B). The (46) , and heated at 95°C for 5 min. The resulting whole-cell extracts were resolved on SDS-polyacrylamide gels, which were subsequently stained and destained briefly, dried, and exposed to Cronex-4 X-ray film (Dupont Canada, Mississauga, Ontario) for 24 h. In vitro mutagenesis and gene replacement. To construct P. aeruginosa strains mutated in ORFC (see Fig. 6 ), ORFC was first isolated on a 4-kb PstI fragment derived from pPV20 and then cloned into the unique PstI site on pSUP301 (68) to yield pPV21. Plasmid pPV21 was partially digested with BamHI, which cuts once in pSUP301 and once in ORFC, and fulllength DNA was recovered from agarose gels. Full-length DNA was identified by simultaneously running an EcoRI digest of the same DNA. The mercury resistance determinant of plasmid pPH45fQHg (22) was isolated as a BamHI fragment which was subsequently ligated to BamHI-digested (partially) pPV21 and transformed into E. coli 5K. Plasmids carrying the mercury resistance determinant within ORFC were identified via restriction analysis. One such plasmid (pPV22) was transformed into mobilizing E. coli S17-1 (68), which was subsequently conjugated with P. aeruginosa strains by pelleting equal 
RESULTS
Identification of a 50-kDa outer membrane protein in mutants of P. aeruginosa growing in the presence of 2,2'-dipyridyl. In an attempt to identify outer membrane components involved in iron acquisition in P. aeruginosa, spontaneous mutants of strain K372 able to grow in the presence of growth-inhibitory concentrations of the nonmetabolizable iron chelator 2,2'-dipyridyl (0.5 mM) were isolated, and outer membranes were screened for the presence of novel proteins. It was reasoned that the ability to grow under such ironrestricted conditions would necessitate an improvement in the iron-acquiring ability of the mutants and that their characterization might identify outer membrane proteins involved in iron uptake. A number of mutants capable of growth in the presence of 0.5 mM 2,2'-dipyridyl were recovered, and many of these (e.g., strain K385) expressed high levels of a 50-kDa outer membrane protein (Fig. IA, of the protein was, however, achieved by growth in HEPESbased iron-deficient minimal medium (Fig. 2, lane 5) . In addition, extended (24 to 36 h) incubation of K372 in the presence of 0.5 mM 2,2'-dipyridyl resulted in the growth of K372 and the concomitant induction of OprK (Fig. 2, lane 3) . Interestingly, maximal production of the protein was achieved by growth in the presence of ZnSO4 (Fig. 2, lane 7) .
Susceptibility of K385 to antimicrobial agents. The production of a 50-kDa outer membrane protein was previously observed for mutants of P. aeruginosa resistant to streptonigrin (56) , and K385 exhibited enhanced resistance to this compound (Table 2 ). This association between the production of a 50-kDa outer membrane protein and resistance to an antimicrobial agent was intriguing, since a number of previously reported quinolone-resistant P. aeruginosa strains also produced novel outer membrane proteins with a ca. 50-kDa molecular mass (24, 33, 43) . Furthermore, these mutants showed cross-resistance to additional nonquinolone antibiotics. Examination of the antibiotic susceptibility of K385 revealed that it too exhibited resistance to quinolones (ciprofloxacin and nalidixic acid) as well as to chloramphenicol and tetracycline (Table 2) .
Overproduction of cytoplasmic membrane proteins in K385.
Quinolone-resistant E. coli and multiple-antibiotic-resistant E.
coli have been described (11, 32, 37, 38) , and resistance has, in part, been attributable to an efflux component located in the cytoplasmic membrane (10) . To determine whether the resistance phenotype of K385 was characterized by alterations in the cytoplasmic membrane, in addition to overproduction of outer membrane protein OprK, cytoplasmic membrane fractions were prepared from K385 and its parent and examined (57) ; to determine whether OprK was the product of ORFC, its sequence was completed (Fig. 4) . ORFC, which begins 2 bp downstream from the stop codon of ORFB, encompasses 1,430 bp and is predicted to encode a product of 476 amino acids (excluding the initiation methionine) and with a molecular mass of 51,481 Da. The deduced ORFC product possesses a sequence at its N terminus characteristic of signal sequences as well as a putative lipoprotein signal peptidase cleavage site (75) . The predicted mature polypeptide comprises 460 amino acids and has a molecular mass of 50,010 Da. The expression of ORFC on a 6.5-kb SmaI-HindIll fragment (Fig. 3B ) in E. coli by use of the phage T7-based expression system (70) yielded a major product of 49 kDa and a minor product of 51 kDa (Fig. 5) . This result was in excellent agreement with the predicted molecular masses of the mature and precursor forms, respectively, of the ORFC product and with the estimated molecular mass of OprK. A weakly detected band running above the 97-kDa molecular mass marker is apparently derived from ORFB, most of which is present on the 6.5-kb Smal-HindlIl fragment. N-terminal amino acid sequencing of OprK was unsuccessful, as might be expected for a possible lipoprotein. Problems were also encountered with CNBr digestion of the protein, owing to the apparent acid lability of the protein, although a 43-kDa digestion product was recovered in sufficient quantity for N-terminal amino acid sequencing. The N-terminal sequence obtained for this degradation product (ALXNNRXL) matches the predicted ORFC amino acid sequence beginning at residue 73 (bp 228). Moreover, an ORFC-derived product beginning here would have a molecular mass of 44,110 Da, in good agreement with the estimated size of the OprK-derived CNBr digestion product which was sequenced. Thus, OprK is, indeed, the product of ORFC, which should now be referred to as oprK. Furthermore, it is likely that the cytoplasmic membrane proteins identified in K385 are the products of ORFAB.
Characterization of mutants defective in ORFABC. As the mutation in strain K385 has yet to be mapped or fully characterized, it is possible that additional alterations which may be responsible for the multiple antibiotic resistance phenotype of strain K385 occur. To demonstrate a direct involvement of ORFABC in multiple antibiotic resistance, then, mutants specifically deficient in the ORFABC products were constructed and examined for antibiotic susceptibility. An ORFA mutant had been constructed previously by insertion of the tet gene of plasmid pBR322 into the cloned gene, which was then introduced into P. aeruginosa by gene replacement (57) . Similarly, a stable ORFB mutant had been obtained earlier by insertion of a mini-Tn]O-kan element into the cloned gene, which was also introduced into P. aeruginosa by gene replacement (57) . Finally, an ORFC mutant was constructed (Fig. 6) by insertion of the HgCl2 resistance determinant of pHP45flHg (22) into the cloned gene, which was then introduced into P. aeruginosa by gene replacement. Interestingly, attempts at introducing these mutations into wild-type P. aeruginosa PAO1 or mutant strain K385 were unsuccessful, despite repeated attempts. This was unfortunate, since it precluded direct confirmation that the ORFAB genes were responsible for the production of the cytoplasmic membrane proteins overproduced in K385. Moreover, while mutated ORFA and ORFB were readily introduced into strain K372, the recovery of K372 carrying the ORFB::mini-TnlO-kan mu- tation was complicated by the high frequency with which K372 (and most P. aeruginosa PAO strains) mutates to kanamycin resistance. This is attributable, at least in part, to the presence in P. aeruginosa PAO of a gene, aphA4, which encodes an aminoglycoside 3'-phosphotransferase (53) . Thus, the ORFB::mini-TnlO-kan mutation was introduced into strain K635, a pyoverdine-deficient derivative of aphA mutant strain ML5084 (53) . Strains carrying mutated ORFA (K590), ORFB (K636), and ORFC (K613) all showed increased susceptibility (relative to that of their parent strains) to a number of antibiotics, including tetracycline, chloramphenicol, ciprofloxacin, and the iron-binding compounds streptonigrin and 2,2'-dipyridyl (Table 3) . These data confirm a direct role for the ORFABC operon in antibiotic resistance in P. aeruginosa.
Homology of the ORFABC products to bacterial proteins involved in resistance to antimicrobial agents. The products of ORFAB were previously demonstrated to be highly homologous (40 to 60% identity) to the envCD gene products (57) ( Table 4) , reported to be involved in septum formation in E. coli (42) . Mutants defective in ORFAB were not, however, defective in septum formation, and it was suggested that the envCD gene products were likely not involved directly in septum formation (57) . A more recent scan of the GenBank data library identified an additional pair of proteins, AcrA and AcrB (76) (accession number M94248), exhibiting substantial homology to the ORFAB products (Table 4) . These proteins are the products of an operon responsible for resistance, in E. coli, to acriflavine as well as a number of hydrophobic antibiotics, dyes, and detergents (5). The ORFA product shares 57.7% identity and 8.9% similarity with AcrA while, remarkably, the ORFB product exhibits 69.8% identity and 10.9% similarity with AcrB. The homologous protein pairs are of comparable sizes (Table 4 ) and, like the ORFA product, AcrA possesses the consensus lipoprotein box (data not shown). FusA, the product of a gene required for fusaric acid resistance in Pseudomonas cepacia (71) , was identified as homologous to the oprK (ORFC) product. Although the level of homology between the two proteins over their entire sequences was low (Table 4) , alignment of residues 118 to 380 of OprK and residues 19 to 277 of FusA revealed that 29.4% of the residues were identical and 12.3% were conservative substitutions (data not shown). No homology was observed, however, between the ORFA-ORFB-oprK (ORFC) operon or its products and the recently sequenced E. coli mar (multiple antibiotic resistance) locus (9) (accession number M96235) or its deduced products.
Homology between the ORFABC products and bacterial export proteins. The multiple antibiotic resistance phenotype in E. coli has been attributed, at least in part, to an efflux component present in the cytoplasmic membrane (10) . More 
Nucleotide sequence of ORFC. The deduced amino acid sequence of the ORFC product is also presented, initiating 2 bp downstream from the stop codon of ORFB (Fig. 3) . A lipoprotein box and selected restriction sites are highlighted. The sequence of ORFC up to the XhoI site was published previously (57) . The sequence of ORFC has been deposited in the GenBank data base. additional efflux proteins with homology to the ORFABC products (Table 4) . Proteins exhibiting homology to ORFA included CzcB (51), a cytoplasmic membrane protein involved in cation (heavy metal) efflux in A. eutrophus; HlyD (31), a cytoplasmic membrane protein involved in hemolysin export in E. coli; and LktD (26) , a leukocidin export protein ofActinobacillus actinomycetemcomitans. Similarly, the ORFB product was homologous to a second cation efflux protein, CnrA (45), also from A. eutrophus. Finally, the oprK (ORFC) product showed homology to a number of outer membrane proteins with an export function, including CyaE (cyclolysin export in Bordetella pertussis) (25) and PrtF (protease export in Erwinia chrysanthemi) (44) . It also showed homology to NodT, a predicted outer membrane lipoprotein reportedly involved in nodulation in Rhizobium leguminosarum (69) . The nodT gene is clustered with a number of genes involved in the export of nodulation factors (72) , and the NodT product is presumed to function in nodulation factor export (18) . Interestingly, ORFB is also homologous to two nodulation proteins from Rhizobium meliloti, NodH and NodI, which may also be involved in nodulation factor secretion (3) . Both Nod proteins are markedly smaller than the ORFB product, with NodH exhibiting homology solely to the central region of ORFB, while NodI is homologous to the C terminus of this protein (Table 4) .
DISCUSSION
The production of a 50-kDa outer membrane protein (OprK) in P. aeruginosa K385 was associated with decreased susceptibility to 2,2'-dipyridyl as well as to a number of antimicrobial agents. The previously described norfloxacinresistant P. aeruginosa nfxB (33) and nfxC (24) strains also showed decreased susceptibility to several antimicrobial agents concomitant with the production of 54-and 50-kDa outer membrane proteins, respectively. Unlike the nfxC mutants, however, K385 and the nfxB mutants did not show a decrease in the level of OprD. A ciprofloxacin-resistant mutant of P. aeruginosa exhibiting cross-resistance to nonquinolone antibiotics also expressed a novel outer membrane protein of 54 kDa (43 ofloxacin and cefsulodin (47) . Despite some subtle differences in the resistance phenotypes of the aforementioned mutants, it is tempting to speculate that the outer membrane protein identified in all cases is the same. If so, it is likely that decreased drug accumulation leading to resistance in the nfxB, nfxC, OprM-producing, and ciprofloxacin-resistant mutants was due not to altered outer membrane permeability, as originally suggested, but to antibiotic efflux, given the homology between OprK (i.e., the ORFC product) and several bacterial outer membrane efflux proteins. Interestingly, quinolone resistance and multiple antibiotic resistance in E. coli have also been attributed, in part, to an efflux mechanism (10) .
The similarities in resistance phenotypes exhibited by the aforementioned mutants are also intriguing, in that the cfxB (nalB) mutation (61, 62) and the mutation resulting in the overproduction of OprM (47) have been mapped to the 20-min region of the P. aeruginosa PAO chromosome, while the ORFA-ORFB-oprK (ORFC) operon has been physically mapped to the 16-to 20-min region (21) . In contrast, the nfxC mutation has been mapped near the catA1 gene at min 46 on the P. aeruginosa PAO chromosome (24), the same location at which the gene(s) required for pyoverdine synthesis has been mapped (2) . This is interesting because, as discussed below, the ORFA-ORFB-oprK (ORFC) operon is proposed to play a role in pyoverdine secretion.
In addition to OprK, the ORFA-ORFB-oprK (ORFC) operon encodes two proteins, of 40 brane. For this reason, we propose to rename ORFAB mexAB (multiple efflux). The ORFABC (mexA-mexB-oprK) operon is regulated by iron (57) and, indeed, OprK was inducible under certain conditions of iron limitation. The failure to observe induction of the protein during growth in iron-deficient BM2 minimal medium is probably attributable to substantial iron contamination of the phosphate component of BM2, rendering the medium less iron deficient than other minimal media. This suggests that substantial OprK (and therefore ORFABC [mexA-mexB-oprK]) expression requires more severe iron limitation. OprK was, for example, readily induced during growth in an iron-deficient HEPESbuffered minimal medium, which may be contaminated to a lesser extent with iron. Certainly, siderophore yields are threeto fourfold higher in this medium than in iron-deficient BM2 h Protein sequences exhibiting homology to the products of ORFA (first grouping), ORFB (second grouping), or ORFC (oprK) (third grouping) were individually aligned to the sequence of the appropriate ORFABC product by use of the PCOMPARE program available with the PC Gene software package. The alignment score was obtained by the method of Needleman and Wunsch (50) as implemented by Feng et al. (23) by use of the structure-genetic matrix with a gap penalty of 6 and a bias parameter of 0. A value of >3.0 suggests significant similarity.
Score obtained for alignment of NodH to residues 357 to 569 of the ORFB product.
d Score obtained for alignment of NodI to residues 734 to 1024 of the ORFB product. minimal medium (56) , consistent with a lower iron content. Similarly, growth in the presence of the iron chelator 2,2'-dipyridyl, which would be expected to reduce available iron, resulted in the induction of OprK. The observed induction of OprK by Zn2+ is also consistent with iron regulation of this protein, since Zn2+ is known to enhance the expression of iron-regulated constituents in P. aeruginosa, including siderophores (34, 35) and their receptors (56) . A similar effect of Zn + on siderophore production has been noted for Pseudomonas fluorescens (8) and Azotobacter vinelandii (39) . In the latter instance, Zn2+-enhanced siderophore production was attributable to a reduction in cytoplasmic ferrous iron levels resulting from the inhibition of ferric reductase activity by Zn2+ (40) .
In addition to the iron regulation of ORFABC (mexA-mexBoprK), this operon is also coregulated with components of pyoverdine production and uptake (57), and we have suggested that it functions in pyoverdine secretion (57) . The observed homology between the ORFABC (mexA-mexB-oprK) products and a number of bacterial export proteins is certainly consistent with such a conclusion. Moreover, while antibiotics purported to be substrates of an ORFABC (mexA-mexB-oprK) efflux system are structurally quite distinct, they do retain some common features (an aromatic ring), and most exhibit an ability to bind cations, including iron (6, 20, 49, 56, 73, 77) . In this regard, they resemble the catechol-containing chromophore of pyoverdine (17) . It is possible, then, that ORFABC (mexAmexB-oprK)-dependent drug resistance results from similarities between certain antimicrobial agents and pyoverdine, which may be the true substrate for the ORFABC (mexA-mexB-oprK) efflux system. Obviously, the ORFABC (mexA-mexB-oprK) products exhibit a very broad substrate specificity, and it may be that not only pyoverdine but also metabolites thereof are the natural substrates for this efflux system. Thus, ORFABC (mexAmexB-oprK) may function not only in de novo pyoverdine secretion but also in the secretion of recycled pyoverdine and metabolites resulting from that process.
Precedence for broad substrate specificity in components of iron transport can be found in studies of the E. coli ironregulated outer membrane proteins Fiu (7) and Cir (7, 50) , reportedly involved in the uptake of hydrolytic products of the siderophore enterobactin (52) . These proteins also facilitate the uptake of antibiotics containing iron-chelating moieties, including catechol-substituted 3-lactams (13, 52) .
The strikingly high degree of homology between the OR-FAB (mexAB) products and proteins AcrA and AcrB is a strong indication of a common function. While AcrA and AcrB are putative efflux proteins involved in resistance to acriflavine and other antimicrobial agents (5) , it is unlikely that acriflavine is the normal cellular substrate for these proteins. It is interesting to note, however, that like pyoverdine, the E. coli siderophore enterobactin is a catechol-containing molecule (74) . It is tempting to speculate, therefore, that AcrA and AcrB function in the secretion of enterobactin and/or its metabolites. The previously identified homology between the ORFAB (mexAB) products and EnvCD (57) (which is also highly homologous to AcrAB) suggests that E. coli may possess multiple systems for enterobactin export.
